Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie-Claude Renaud

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
International Urogynecology Journal|September 25, 2021
An in-home rehabilitation program for the treatment of urinary incontinence symptoms in endometrial cancer survivors: a single-case experimental design studyStéphanie Bernard, Linda McLean, Samantha Boucher, et al.
Cell Cycle (Georgetown, Tex.)|March 10, 2017
Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cellsAdnen Faddaoui, Razan Sheta, Magdalena Bachvarova, et al.
Journal of Translational Medicine|November 20, 2020
Development of a 3D functional assay and identification of biomarkers, predictive for response of high-grade serous ovarian cancer (HGSOC) patients to poly-ADP ribose polymerase inhibitors (PARPis): targeted therapyRazan Sheta, Magdalena Bachvarova, Marie Plante, et al.
Plos One|October 15, 2013
Inhibition of RUNX2 transcriptional activity blocks the proliferation, migration and invasion of epithelial ovarian carcinoma cellsZhi-Qiang Wang, Mamadou Keita, Magdalena Bachvarova, et al.
Oncotarget|November 16, 2017
Hic-5 regulates epithelial to mesenchymal transition in ovarian cancer cells in a TGFβ1-independent mannerRazan Sheta, Zhi-Qiang Wang, Magdalena Bachvarova, et al.
Gynecologic Oncology|December 11, 2012
Global methylation profiling in serous ovarian cancer is indicative for distinct aberrant DNA methylation signatures associated with tumor aggressiveness and disease progressionMamadou Keita, Zhi-Qiang Wang, Jean-Francois Pelletier, et al.
Oncotarget|September 16, 2015
BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolismZhi-Qiang Wang, Adnen Faddaoui, Magdalena Bachvarova, et al.
Journal of Surgical Oncology|July 12, 2022
Predicting recurrence and recurrence-free survival in high-grade endometrial cancer using machine learningSabrina Piedimonte, Tomer Feigenberg, Erik Drysdale, et al.
Gynecologic Oncology|August 31, 2013
A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancerDominique Trudel, David P Labbé, Monica Araya-Farias, et al.
Gynecologic Oncology|June 29, 2021
Factors associated with an increased risk of recurrence in patients diagnosed with high-grade endometrial cancer undergoing minimally invasive surgery: A study of the society of gynecologic oncology of Canada (GOC) community of practice (CoP)Tomer Feigenberg, Beatrice Cormier, Walter Henri Gotlieb, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
International Urogynecology Journal|September 25, 2021
An in-home rehabilitation program for the treatment of urinary incontinence symptoms in endometrial cancer survivors: a single-case experimental design studyStéphanie Bernard, Linda McLean, Samantha Boucher, et al.
Cell Cycle (Georgetown, Tex.)|March 10, 2017
Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cellsAdnen Faddaoui, Razan Sheta, Magdalena Bachvarova, et al.
Journal of Translational Medicine|November 20, 2020
Development of a 3D functional assay and identification of biomarkers, predictive for response of high-grade serous ovarian cancer (HGSOC) patients to poly-ADP ribose polymerase inhibitors (PARPis): targeted therapyRazan Sheta, Magdalena Bachvarova, Marie Plante, et al.
Plos One|October 15, 2013
Inhibition of RUNX2 transcriptional activity blocks the proliferation, migration and invasion of epithelial ovarian carcinoma cellsZhi-Qiang Wang, Mamadou Keita, Magdalena Bachvarova, et al.
Oncotarget|November 16, 2017
Hic-5 regulates epithelial to mesenchymal transition in ovarian cancer cells in a TGFβ1-independent mannerRazan Sheta, Zhi-Qiang Wang, Magdalena Bachvarova, et al.
Gynecologic Oncology|December 11, 2012
Global methylation profiling in serous ovarian cancer is indicative for distinct aberrant DNA methylation signatures associated with tumor aggressiveness and disease progressionMamadou Keita, Zhi-Qiang Wang, Jean-Francois Pelletier, et al.
Oncotarget|September 16, 2015
BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolismZhi-Qiang Wang, Adnen Faddaoui, Magdalena Bachvarova, et al.
Journal of Surgical Oncology|July 12, 2022
Predicting recurrence and recurrence-free survival in high-grade endometrial cancer using machine learningSabrina Piedimonte, Tomer Feigenberg, Erik Drysdale, et al.
Gynecologic Oncology|August 31, 2013
A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancerDominique Trudel, David P Labbé, Monica Araya-Farias, et al.
Gynecologic Oncology|June 29, 2021
Factors associated with an increased risk of recurrence in patients diagnosed with high-grade endometrial cancer undergoing minimally invasive surgery: A study of the society of gynecologic oncology of Canada (GOC) community of practice (CoP)Tomer Feigenberg, Beatrice Cormier, Walter Henri Gotlieb, et al.
Pageof 7